A polyclonal antibody that recognizes pThr 175 tau was used in the analysis of tau-immunoreactive inclusions in ALS patients, revealing that widespread alteration of tau is also associated with an increase in TDP-43 immunoreactivity [23]. The gene discussed is MAPT; the disease is amyotrophic lateral sclerosis.